GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heron Therapeutics Inc (LTS:0J4V) » Definitions » Shiller PE Ratio

Heron Therapeutics (LTS:0J4V) Shiller PE Ratio : (As of Jun. 09, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Heron Therapeutics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Heron Therapeutics Shiller PE Ratio Historical Data

The historical data trend for Heron Therapeutics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heron Therapeutics Shiller PE Ratio Chart

Heron Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Heron Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Heron Therapeutics's Shiller PE Ratio

For the Biotechnology subindustry, Heron Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heron Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heron Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Heron Therapeutics's Shiller PE Ratio falls into.



Heron Therapeutics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Heron Therapeutics's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Heron Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.02/131.7762*131.7762
=-0.020

Current CPI (Mar. 2024) = 131.7762.

Heron Therapeutics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.780 100.560 -1.022
201409 -0.660 100.428 -0.866
201412 -0.710 99.070 -0.944
201503 -0.700 99.621 -0.926
201506 -0.740 100.684 -0.969
201509 -0.630 100.392 -0.827
201512 -0.870 99.792 -1.149
201603 -0.920 100.470 -1.207
201606 -1.170 101.688 -1.516
201609 -1.240 101.861 -1.604
201612 -1.220 101.863 -1.578
201703 -1.000 102.862 -1.281
201706 -0.800 103.349 -1.020
201709 -0.770 104.136 -0.974
201712 -1.100 104.011 -1.394
201803 -0.810 105.290 -1.014
201806 -0.540 106.317 -0.669
201809 -0.490 106.507 -0.606
201812 -0.630 105.998 -0.783
201903 -0.800 107.251 -0.983
201906 -0.630 108.070 -0.768
201909 -0.420 108.329 -0.511
201912 -0.650 108.420 -0.790
202003 -0.570 108.902 -0.690
202006 -0.610 108.767 -0.739
202009 -0.640 109.815 -0.768
202012 -0.680 109.897 -0.815
202103 -0.580 111.754 -0.684
202106 -0.620 114.631 -0.713
202109 -0.510 115.734 -0.581
202112 -0.540 117.630 -0.605
202203 -0.630 121.301 -0.684
202206 -0.550 125.017 -0.580
202209 -0.380 125.227 -0.400
202212 -0.170 125.222 -0.179
202303 -0.270 127.348 -0.279
202306 -0.350 128.729 -0.358
202309 -0.170 129.860 -0.173
202312 -0.050 129.419 -0.051
202403 -0.020 131.776 -0.020

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Heron Therapeutics  (LTS:0J4V) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Heron Therapeutics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Heron Therapeutics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Heron Therapeutics (LTS:0J4V) Business Description

Traded in Other Exchanges
Address
4242 Campus Point Court, Suite 200, San Diego, CA, USA, 92121
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.

Heron Therapeutics (LTS:0J4V) Headlines

No Headlines